Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes   Bogaards Johannes A  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite

The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical Cancer

By Fisher S.G.   Benitez-Bribiesca L.   Nindl I.   Stockfleth E.   Muller M.   Wolf H.   Perez-Garcia F.   Guzman-Gaona J.   Gutierrez-delgado F.   Irvin W.   Gissmann L.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 73-78

Academic Press

Access to resources Recommend Favorite

Human Papillomavirus Type 16 E6 and E7 Gene Variations in Indian Cervical Cancer

By Radhakrishna Pillai M.   Sreevidya S.   Pollock B.H.   Jayaprakash P.G.   Herman B.  

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 268-273

Academic Press

Access to resources Recommend Favorite

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

By Hallez Sophie   Simon Philippe   Maudoux Frédéric   Doyen Jean   Noël Jean-Christophe   Beliard Aude   Capelle Xavier   Buxant Frédéric   Fayt Isabelle   Lagrost Anne-Cécile   Hubert Pascale   Gerday Colette   Burny Arsène   Boniver Jacques   Foidart Jean-Michel   Delvenne Philippe   Jacobs Nathalie  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 642-650

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

By Du Juan   Näsman Anders   Carlson Joseph W.   Ramqvist Torbjörn   Dalianis Tina  

Acta Oncologica, Vol. 50, Iss. 8, 2011-11 ,pp. : 1215-1219

Informa Healthcare

Access to resources Recommend Favorite